• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Teva Pharmaceutical Industries Ltd - Articles and news items

fertility preservation

Teva supports IVF Worldwide to improve knowledge of fertility preservation protocols

Industry news / 10 March 2016 / Victoria White

Teva is to support IVF-Worldwide with a research grant to improve knowledge of fertility preservation protocols for women diagnosed with cancer…

pharmaceutical industry

European Pharmaceutical Review’s top 10 stories from 2015

Blog / 28 January 2016 / Victoria White, Digital Content Producer, European Pharmaceutical Review

2015 was an interesting year for the pharmaceutical industry. Here we pick a selection of the top stories that hit the headlines…

rimsa

Teva acquires Mexican company Rimsa for $2.3b

Industry news / 2 October 2015 / Victoria White

Through the Rimsa acquisition, Teva will become a leading pharmaceutical company in the second largest market in Latin America…

reslizumab

Teva files MAA for asthma treatment reslizumab

Industry news / 28 July 2015 / Victoria White

Teva has successfully filed a MAA with the EMA for reslizumab -a humanised anti-IL-5 monoclonal antibody for the treatment of inadequately controlled asthma…

teva

Teva withdraws proposal to acquire Mylan

Industry news / 28 July 2015 / Victoria White

Following yesterday’s news that Teva is to acquire Allergan’s global generics business, Teva has withdrawn its cash and stock proposal to acquire Mylan…

eluxadoline

Allergan to acquire Naurex; divests generics business to Teva

Industry news / 27 July 2015 / Victoria White

Allergan followed an announcement it made yesterday about its acquisition of Naurex with news today that it is to divest its generics business to Teva…

axert

Teva first to receive approval and launch generic Axert tablets in the US

Industry news / 9 July 2015 / Victoria White

Teva has launched generic Axert® (almotriptan malate) tablets in the US for the treatment of migraine attacks in adults and adolescents…

spiromax

Teva’s DuoResp Spiromax wins silver at the 2015 Medical Design Excellence Awards

Industry news / 2 July 2015 / Victoria White

Teva’s DuoResp Spiromax inhaler for patients with asthma and COPD has won silver at the 2015 Medical Design Excellence Awards (MDEA)…

TV-45070

Teva and Xenon provide update on TV-45070 Phase 2b study in osteoarthritis pain

Industry news / 1 July 2015 / Victoria White

Teva and Xenon have reported top line results from a Phase 2b study designed to evaluate the safety and efficacy of TV-45070 in patients with osteoarthritis…

seasonique

Teva launches Seasonique extended-regimen contraceptive in first European markets

Industry news / 1 July 2015 / Victoria White

Teva Europe has announced the first European launches of its extended-regimen oral contraceptive, Seasonique for the prevention of pregnancy…

laquinimod

Patient enrollment in Phase III CONCERTO trial of laquinimod completed

Industry news / 25 June 2015 / Victoria White

The patient enrollment for the Phase III CONCERTO trial of laquinimod in patients with relapsing-remitting multiple sclerosis (RRMS) has been finalised…

SD-809

Teva announces positive top-line results from a study evaluating SD-809 in tardive dyskinesia

Industry news / 16 June 2015 / Victoria White

Teva has announced positive top-line results from a study designed to evaluate the efficacy of SD-809 in the treatment of tardive dyskinesia…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +